SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch 
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions 
AstraZeneca, Bristol Myers Squibb Explore Mega Merger Worth Nearly $400 Billion 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring 
HSBC H1 Profit Jumps 23%, Announces $1 Billion Share Buyback and Reaffirms 2028 Targets 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip 
Jetstar to Charge for Overhead Cabin Bags From February 
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook 
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan 
DHL Q2 Profit Jumps 24% as Express Business Drives Growth 
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August 
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners 
Boeing Stock Jumps as FAA Certifies 737 MAX-7 After Years of Regulatory Review 
Capital One Says AML Review Led to Closure of Trump Organization Accounts 
NEW ORLEANS, March 30, 2018 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until April 6, 2018 to file lead plaintiff applications in a securities class action lawsuit against MetLife, Inc. (NYSE:MET), if they purchased the Company’s securities between February 27, 2013 and January 29, 2018, inclusive (the “Class Period”). This action is pending in the United States District Court for the Eastern District of New York.
Get Help
MetLife investors should visit us at https://www.claimsfiler.com/cases/view-metlife-inc-securities-litigation-1 or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
MetLife and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On January 29, 2018, MetLife disclosed “a material weakness in internal controls over financial reporting” that caused reserves to be reduced incorrectly relating to outstanding payouts for annuity and pension recipients and that its Q4 earnings release was postponed, with reserves expected to increase by $525 million to $575 million, Q4 earnings to decrease by $135 million to $165 million, and 2017 profits cut by $165 million to $195 million. MetLife also revealed a SEC investigation into the outstanding pension payments matter.
On this news, the price of MetLife’s shares plummeted.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.
